Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915473 · ClinicalTrials.gov registry record · Phase 4
Greater Occipital Nerve Block for Migraine Prophylaxis
A Phase 4 study of Migraine Headache, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00915473: Completed Phase 4 study of Migraine Headache, sponsored by Mayo Clinic.
NCT00915473 is a Phase 4 study of Migraine Headache that has completed, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 148-participant average among 6 other Migraine Headache trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00915473, a Phase 4 study of Migraine Headache, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or severe headache in patients with episodic or chronic migraine.
Primary Outcome
The baseline frequency will be the number of calendar days with moderate or severe migraine during the 4 week period prior to injection, and the follow-up frequency will be the number of calendar days with migraine during the 4 week period following injection.
Conditions Studied
Interventions
- DRUG methylprednisolone
- DRUG normal saline
- DRUG lidocaine
- DRUG bupivicaine
Study Locations (1)
Arizona
- Mayo Clinic - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
What the finished NCT00915473 record still lists
NCT00915473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 148-participant average among 6 other Migraine Headache trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Migraine Headache appearing as the primary indexed condition, and to 4 interventions - of which methylprednisolone is the first listed.
NCT00915473 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00915473 about?
NCT00915473 is a clinical study titled "Greater Occipital Nerve Block for Migraine Prophylaxis". Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Grea...
What is the current status of trial NCT00915473?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2009-06. Estimated completion is 2013-01.
What conditions does trial NCT00915473 study?
This clinical trial studies the following conditions: Migraine Headache.
What interventions are being tested in trial NCT00915473?
The interventions under investigation include: methylprednisolone (DRUG), normal saline (DRUG), lidocaine (DRUG), bupivicaine (DRUG).
Who is sponsoring clinical trial NCT00915473?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00915473 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure, Migraine Outcomes, and Sleep Quality
RECRUITING · NA
-
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
COMPLETED · NA
-
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
COMPLETED · NA
-
Efficacy, Tolerability, and Safety of DFN-15
COMPLETED · Phase 3
-
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
COMPLETED · Phase 2
-
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia